Cargando…
Intracerebroventricular Administration of Human Umbilical Cord Blood—Derived Mesenchymal Stem Cells Induces Transient Inflammation in a Transgenic Mouse Model and Patients with Alzheimer’s Disease
Previously we conducted a Phase I/IIa clinical trial in nine patients with mild to moderate Alzheimer’s disease (AD). Unexpectedly, all patients who were given injections of human-umbilical cord-blood-derived mesenchymal stem cells (hUCB-MSCs) developed fever which subsided after 24 h. Several possi...
Autores principales: | Myeong, Su Hyeon, Kim, Hyeongseop, Lee, Na Kyung, Hwang, Jung Won, Kim, Hee Jin, Jang, Hyemin, Choi, Soo Jin, Na, Duk L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945031/ https://www.ncbi.nlm.nih.gov/pubmed/35327365 http://dx.doi.org/10.3390/biomedicines10030563 |
Ejemplares similares
-
Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer’s disease dementia: a phase I clinical trial
por: Kim, Hee Jin, et al.
Publicado: (2021) -
PT577. Distribution of Human Umbilical Cord Blood-derived Mesenchymal Stem Cells (hUCB-MSCs) in the Alzheimer’s Disease Transgenic Mouse after a Single Intravenous Injection
por: Park, Sang Eon, et al.
Publicado: (2016) -
Intrathecal Injection in a Rat Model: A Potential Route to Deliver Human Wharton’s Jelly-Derived Mesenchymal Stem Cells into the Brain
por: Kim, Hyeongseop, et al.
Publicado: (2020) -
Identification of potential biomarkers related to mesenchymal stem cell response in patients with Alzheimer’s disease
por: Choi, Yejoo, et al.
Publicado: (2023) -
Immunosuppressant Drugs Mitigate Immune Responses Generated by Human Mesenchymal Stem Cells Transplanted into the Mouse Parenchyma
por: Hwang, Jung Won, et al.
Publicado: (2021)